Werner Enterprises: Hudson Appoints Werner Maas to Boost Innovation in Lab Automation

Hudson Appoints Werner Maas as New CEO, Aiming for Enhanced Innovation in Laboratory Automation

On November 4, 2024, Hudson, a prominent player in the laboratory automation sector, announces the appointment of Werner Maas as its new Chief Executive Officer. Maas, who comes with a wealth of experience in the life sciences tools industry, previously led the Global Liquid Handling division at Mettler Toledo, overseeing its Rainin and Biotix business units. His expertise also extends to leading the Magnetic Resonance division at Bruker Biospin Group. In his new role at Hudson, Maas focuses on elevating the company’s innovative solutions and product offerings, which are pivotal for improving productivity and reproducibility in scientific research.

Maas's leadership arrives at a crucial time as Hudson integrates three recently acquired companies: Hudson Robotics, Art Robbins Instruments, and Tomtec. Dr. Ian Shuttler, Executive Chairman of Hudson, expresses enthusiasm for Maas's strategic vision, highlighting the importance of creating a unified, customer-focused organization that leverages the strengths of these acquisitions. This consolidation aims to streamline operations and enhance the value proposition for clients in the pharmaceutical, biopharma, academic, and OEM markets where Hudson operates.

Under Maas's guidance, Hudson sets its sights on reinforcing its commitment to quality, reliability, and cutting-edge innovation in laboratory automation. The company specializes in designing, assembling, and integrating liquid handling systems, microplate automation, and laboratory robotics—critical tools utilized in drug discovery and clinical research. As it looks to expand its market presence, Hudson is well-positioned to capitalize on its strong foundation, particularly in an industry that increasingly demands sophisticated automation solutions for enhanced research efficiency.

In addition to Maas's appointment, Andrew Witschi takes on the role of President of Hudson Robotics and Head of Technology. This dual leadership structure signifies Hudson's dedication to technological advancement and operational excellence in the evolving landscape of laboratory automation. The recent changes reflect a strategic commitment to meet the growing demands of the scientific community while fostering an innovative environment.

As Hudson continues to enhance its offerings and solidify its market position, the leadership changes are anticipated to drive significant advancements in the quality of automation solutions available to researchers, thereby contributing to the overall progress in scientific exploration and discovery.